Dialysis
Hemofiltration may trap and destroy hepatitis C virus particles
Published in Hepatitis Weekly, June 14th, 2004
"Low incidence rates of hepatocellular carcinoma and cirrhosis in HCV-antibody-positive patients on chronic hemodialysis are reported. Among the patients, two cases undergoing negative conversion of the anti-HCV-antibody were found. Considering the size of the virus particles and the pore size of the dialysis membrane, it seems the virus does not escape from the membrane pore," investigators in Japan report.
"Indeed, virus particles may be trapped and destroyed at the membrane surface. The size of HCV-RNA titers in HCV-antibody-positive patients receiving various kinds of chronic blood...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-06-14)
More Articles from Hepatitis Weekly
- Autoimmune Disease
Diagnoses of zone 3 hepatitis-related autoimmune hepatitis avert cirrhosis - Drug Detection
Liquid chromatography-tandem mass spectrometry measures PMEA in human sera - Hepatitis C Virus Therapy
Interactions between HCV NS5A protein and 2-tAS counteract interferon - Infectious Disease
Hepatitis E virus causes non-A, non-B, non-C acute hepatitis in Japan - Angiology
Increased vascular HO-1 expression contributes to vasodilation in cirrhotic rats - Apoptosis
Cleaved form of MAGE-A4 binds to Miz-1 and induces apoptosis in human cells - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
